Local immunotherapy with Dermatophagoides extract in asthma

Area of Science:

• Allergy and Immunology
• Pulmonology
• Pharmacology

Background:

• Allergic asthma affects millions globally, necessitating effective treatment options.
• Current immunotherapies can be burdensome; novel approaches are under investigation.
• Dermatophagoides extract is a common allergen implicated in allergic asthma.

Purpose of the Study:

• To evaluate the efficacy and safety of local immunotherapy (LIT) with Dermatophagoides extract in patients with allergic asthma.
• To compare the effects of LIT versus placebo on bronchial sensitivity and asthmatic reactions.

Main Methods:

• A double-blind study involving 22 patients with allergic asthma, randomized into LIT and placebo groups.
• Patients received either Dermatophagoides extract or placebo, alongside cromolyn sodium.
• Bronchial provocation tests, symptom scores, drug consumption, and peak expiratory flow were assessed before, during, and after treatment.

Main Results:

• LIT significantly reduced early bronchial sensitivity to allergen at 1 and 4 weeks post-treatment (p < 0.0005 and p < 0.01, respectively).
• Late bronchial reactions to allergen were similar between LIT and placebo groups.
• Despite increased allergen doses in the LIT group to elicit early reactions, the severity of late reactions remained unchanged.

Conclusions:

• Local immunotherapy with Dermatophagoides extract demonstrates potential as an effective and safe alternative to traditional immunotherapy for allergic asthma.
• LIT may modulate bronchial responses to allergens, particularly early-phase reactions.